BIOMAT Database Logo BIOMAT Database Logo

[Parkinsonian syndrome during a treatment with veralipride]. 1991

L Milandre, and A Ali Cherif, and R Khalil

UI MeSH Term Description Entries
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013469 Sulpiride A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed) Aiglonyl,Arminol,Deponerton,Desisulpid,Digton,Dogmatil,Dolmatil,Eglonyl,Ekilid,Guastil,Lebopride,Meresa,Pontiride,Psicocen,Sulp,Sulperide,Sulpitil,Sulpivert,Sulpor,Synédil,Tepavil,Vertigo-Meresa,neogama,vertigo-neogama,Vertigo Meresa,vertigo neogama

Related Publications

L Milandre, and A Ali Cherif, and R Khalil
[Early excitomotor syndrome during treatment with veralipride].
March 1984, LARC medical,
L Milandre, and A Ali Cherif, and R Khalil
[Electrophysiological findings during treatment of the parkinsonian syndrome with amantadine].
October 1971, Minerva medica,
L Milandre, and A Ali Cherif, and R Khalil
Treatment of Parkinsonian syndrome with dexetimide.
January 1979, Acta psychiatrica Belgica,
L Milandre, and A Ali Cherif, and R Khalil
[Parkinson syndrome induced by veralipride].
June 1995, Minerva ginecologica,
L Milandre, and A Ali Cherif, and R Khalil
[Parkinsonian syndrome during viral meningoencephalitis].
January 1991, Rivista di neurologia,
L Milandre, and A Ali Cherif, and R Khalil
Veralipride for hot flushes during gonadotropin-releasing hormone agonist treatment.
January 1992, Gynecologic and obstetric investigation,
L Milandre, and A Ali Cherif, and R Khalil
[Veralipride: treatment of climacteric disorders].
June 1985, Revue francaise de gynecologie et d'obstetrique,
L Milandre, and A Ali Cherif, and R Khalil
[Preliminary psychological findings during treatment of the parkinsonian syndrome with amantadine. Preliminary observations].
October 1971, Minerva medica,
L Milandre, and A Ali Cherif, and R Khalil
[Treatment of menopausal hot flushes with a nonhormonal medication, veralipride].
November 1982, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
L Milandre, and A Ali Cherif, and R Khalil
[Parkinsonian syndrome. Etiology, diagnosis, treatment].
November 1990, La Revue du praticien,
Copied contents to your clipboard!